Biocon Electric files DRHP with SEBI for 59-lakh-share IPO

The Development

Biocon Electric Limited, a Delhi-headquartered electrical products manufacturer, has filed its draft red herring prospectus (DRHP) with the Securities and Exchange Board of India. The draft offer document, dated 29 September 2026, appears under SEBI's public-issues filings, with the abridged prospectus carrying a filing date of 30 September 2026. (This company trades under the "BIOCON" electrical brand and is unrelated to the pharmaceuticals group of a similar name.)

The proposed offer is a book-built issue combining a fresh issue of up to 48,00,000 equity shares with an offer for sale of up to 11,00,000 equity shares, for a total of up to 59,00,000 equity shares of face value Rs 10 each, per the DRHP. The equity shares are proposed to be listed on both BSE Limited and the National Stock Exchange of India.

At this stage the filing is a draft, not an approved IPO. The DRHP seeks SEBI's observations and may be revised, delayed or withdrawn before any issue opens. The price band, the issue size in rupee terms, the lot size and the bid dates are all marked as pending in the draft, to be fixed at the red herring prospectus stage. The filing was surfaced via the Economic Times IPO desk.

The Company

Per the DRHP, Biocon Electric describes itself as a "branded, diversified, multi-category electrical products company" operating under the "BIOCON" brand. Its portfolio spans PVC insulated wires and tape, lighting solutions, electrical switches and accessories, miniature circuit breakers (MCBs), residual current circuit breakers (RCCBs) and other switchgear, and other electrical appliances, running to more than 1,500 stock-keeping units. As of 31 March 2026, the company discloses a distribution network of 1,915 channel partners, comprising 1,531 dealers and 384 distributors, across 25 states and four union territories, supported by more than 10,000 registered electricians. It operates three production facilities, at Delhi, Ghaziabad in Uttar Pradesh and Vasai in Maharashtra.

On financials, the company discloses revenue from operations of Rs 19,673.37 lakh (about Rs 196.73 crore) in Fiscal 2026, up 37.94% from Rs 14,262.42 lakh in Fiscal 2025 and Rs 13,645.24 lakh in Fiscal 2024. Profit after tax was Rs 1,414.05 lakh in Fiscal 2026, against Rs 1,150.00 lakh and Rs 1,099.86 lakh in the two preceding years. The DRHP reports net worth of Rs 6,591.59 lakh, a return on net worth of 21.45% and total borrowings of Rs 7,323.07 lakh (a debt-to-equity ratio of 1.11). The company also discloses that Rs 2,526.63 lakh, or 12.84% of Fiscal 2026 revenue, arose from a one-time aluminium-rod trading transaction. The promoters are Prakash Chand Jain, Ranjeet Kumar Jain, Praveen Kumar Jain, Vikram Kumar and Milap Chand Jain, who together held 90% of the pre-offer equity capital.

The Offer Structure

Per the DRHP, the offer is made through the book-building process under Regulation 6(1) of the SEBI ICDR Regulations. The fresh issue is up to 48,00,000 equity shares and the offer for sale is up to 11,00,000 equity shares, with each of the five promoters offering up to 2,20,000 shares as a promoter selling shareholder. Proceeds from the offer for sale accrue to the selling shareholders, while the fresh-issue proceeds go to the company.

The stated objects of the fresh issue are funding working capital requirements of up to Rs 6,257.45 lakh (about Rs 62.57 crore) and general corporate purposes, the document states. The book-running lead manager is GYR Capital Advisors Private Limited and the registrar is Bigshare Services Private Limited. The price band, lot size, minimum application amount and issue dates remain to be set at the red herring prospectus stage. Readers working through the arithmetic of a lump-sum application can use Oquilia's lumpsum calculator or CAGR calculator, and prior coverage sits on the Oquilia news desk.

Risk Factors

The DRHP sets out the material risks the company is required to disclose. Among them, the company discloses that its distribution network is concentrated in southern India, where 1,427 of its 1,915 channel partners, including 1,377 of its 1,531 dealers, were located as of 31 March 2026. It also notes that its manufacturing, processing and assembly activities are carried out at a limited number of facilities.

The RHP lists supplier concentration as a risk, with purchases from its top ten suppliers representing 67.67% of total material purchases in Fiscal 2026, and overseas procurement, concentrated in China and Vietnam, accounting for 31.51% of material purchases that year. The document further discloses that PVC insulated wires and tapes and lighting solutions together contributed 75.53% of Fiscal 2026 revenue, and that the Rs 2,526.63 lakh one-time trading transaction means the historical rate of revenue growth "may not be indicative of future performance". The company adds that it is party to certain civil and tax proceedings.

What Happens Next

From the current milestone, the standard primary-market sequence runs from draft to listing. SEBI reviews the DRHP and in due course issues its observations. Those observations are a clearance to proceed and are explicitly not an endorsement of the issue or a guarantee of its merits; the draft itself records that the shares have not been recommended or approved by SEBI and that SEBI does not guarantee the accuracy of the document.

Only after observations would the company file a red herring prospectus setting the price band and bid dates, followed by anchor allocation one working day before the issue opens, a three-day subscription window, the basis of allotment, unblocking of funds for unsuccessful bidders, and listing on the BSE and the NSE. None of those dates has been announced.

FAQ

Should I apply for this IPO?

Oquilia does not make recommendations. This report is informational and is not investment advice or a recommendation to subscribe. The DRHP, including the complete risk-factors section, is available on SEBI's website and will be followed by the RHP on the exchanges. Read it directly before making any decision.

What is the size of the Biocon Electric offer?

Per the DRHP, the offer comprises a fresh issue of up to 48,00,000 equity shares and an offer for sale of up to 11,00,000 equity shares, for a total of up to 59,00,000 equity shares of face value Rs 10 each. The rupee size depends on the price band, which has not yet been set.

What do SEBI's observations mean?

SEBI's observations, once issued, are a clearance allowing the issue to proceed. They are not an approval of the issue's merits or an endorsement, and SEBI does not guarantee the accuracy or adequacy of the offer document. The company must incorporate the observations before filing its RHP.

What are the objects of the fresh issue?

The DRHP states the fresh-issue proceeds are intended for funding working capital requirements of up to Rs 6,257.45 lakh and for general corporate purposes. Proceeds from the offer-for-sale portion go to the five promoter selling shareholders, not to the company.

Where can I read the DRHP?

The draft red herring prospectus is available on SEBI's website under its public-issues filings, and the offer document will also be hosted on the websites of the BSE, the NSE and the book-running lead manager.

This report is based on the draft red herring prospectus filed with SEBI by Biocon Electric Limited. It was surfaced via coverage from The Economic Times IPO desk.